NASDAQ
WMGI

Wright Medical Group N.V

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Wright Medical Group N.V Stock Price

Vitals

Today's Low:
$29.9800
Today's High:
$29.9800
Open Price:
$29.9800
52W Low:
$19.09
52W High:
$30.66
Prev. Close:
$29.9800
Volume:
9689

Company Statistics

Market Cap.:
$3.964 billion
Book Value:
6.516
Revenue TTM:
$0.810 billion
Operating Margin TTM:
-2.21%
Gross Profit TTM:
$0.000 billion
Gross Profit TTM:
$0.000 billion
Profit Margin:
-16.57%
Return on Assets TTM:
-0.42%
Return on Equity TTM:
-12.31%

Company Profile

Wright Medical Group N.V had its IPO on 2001-07-17 under the ticker symbol WMGI.

The company operates in the Healthcare sector and Medical Devices industry. Wright Medical Group N.V has a staff strength of 3,030 employees.

Stock update

Shares of Wright Medical Group N.V opened at $29.98 at the start of the last trading session i.e. 2020-11-11.

The stocks traded within a range of $29.98 - $29.98, and closed at $29.98.

This is a 0% increase from the previous day's closing price.

A total volume of 9,689 shares were traded at the close of the day’s session.

In the last one week, shares of Wright Medical Group N.V have slipped by -3.29%.

Wright Medical Group N.V's Key Ratios

Wright Medical Group N.V has a market cap of $3.964 billion, indicating a price to book ratio of 4.6913 and a price to sales ratio of 4.8098.

In the last 12-months Wright Medical Group N.V’s revenue was $0.810 billion with a gross profit of $0.000 billion and an EBITDA of $0.079 billion. The EBITDA ratio measures Wright Medical Group N.V's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Wright Medical Group N.V’s operating margin was -2.21% while its return on assets stood at -0.42% with a return of equity of -12.31%.

In Q2, Wright Medical Group N.V’s quarterly earnings growth was a positive 0% while revenue growth was a negative 43.4%.

Wright Medical Group N.V’s PE and PEG Ratio

Forward PE
82.6446
Trailing PE
0
PEG
-6.14

Its diluted EPS in the last 12-months stands at $-1.048 per share while it has a forward price to earnings multiple of 82.6446 and a PEG multiple of -6.14. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Wright Medical Group N.V’s profitability.

Wright Medical Group N.V stock is trading at a EV to sales ratio of 6.2042 and a EV to EBITDA ratio of 62.9908. Its price to sales ratio in the trailing 12-months stood at 4.8098.

Wright Medical Group N.V stock pays annual dividends of $None per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Wright Medical Group N.V ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Wright Medical Group N.V ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Wright Medical Group N.V’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Wright Medical Group N.V's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Wright Medical Group N.V paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$29.98
52-Week High
$30.66
52-Week Low
$19.09
Analyst Target Price
$30.5

Wright Medical Group N.V stock is currently trading at $29.98 per share. It touched a 52-week high of $30.66 and a 52-week low of $30.66. Analysts tracking the stock have a 12-month average target price of $30.5.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 15.89 indicating a short percent outstanding of 14%.

Around 98.9% of the company’s stock are held by insiders while 11332% are held by institutions.

Frequently Asked Questions About Wright Medical Group N.V

The stock symbol (also called stock or share ticker) of Wright Medical Group N.V is WMGI

The IPO of Wright Medical Group N.V took place on 2001-07-17

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$0.42
0
+0.33%
Soliton, Inc (SOLY)
$22.58
0
0%
$3.14
-1.41
-30.99%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.

Address

Prins Bernhardplein 200, Amsterdam, Netherlands, 1097 JB